Loading
companiesCompany
Tolmar
Tolmar is a privately held Colorado company that makes Eligard, the subcutaneous depot of the hormone therapy leuprolide used to suppress testosterone in advanced prostate cancer.
Also called: Tolmar Inc.Tolmar Pharmaceuticals
Overview
Tolmar, based in Fort Collins, Colorado, develops and manufactures long-acting injectables using its Atrigel polymer depot technology. Its main product is Eligard (leuprolide acetate for injectable suspension), a gonadotropin-releasing hormone agonist given every one to six months for palliative treatment of advanced prostate cancer, sold in the United States by Tolmar and abroad through partners; it runs phase 3 trials of new formulations and dosing intervals. It appears on OnCo as a lead sponsor of phase 3 cancer trials on ClinicalTrials.gov.
Headquarters
Fort Collins, CO, US
Scorecard
All companies#224of 1244 companies, score 24
- approved products +6
- targets +2
- modalities +2
- regions +6
- registry trials +8
1 approved, 0 in phase 3, 0 earlier, 1 targets, 16 registry studies. Formula on the scorecards page.
Type
Stage
Large private
Website
ApprovedGnRH agonist depot
Leuprolide (leuprorelin) and GnRH agonists · Lupron / Eligard / Camcevi
Leuprolide is the injectable that shuts off testosterone production, the foundation of hormone therapy for prostate cancer since the 1980s; it is also used for ovarian suppression in premenopausal breast cancer.
Similar pages
- TreatmentAbarelix
Shares GnRH receptor (GNRHR), Leuprolide (leuprorelin) and GnRH agonists, Prostate cancer.
- CompanyVerity Pharmaceuticals
Shares GnRH receptor (GNRHR), Prostate cancer.
- CompanyForesee Pharmaceuticals
Shares Leuprolide (leuprorelin) and GnRH agonists, Prostate cancer.
- CompanyOakwood Laboratories
Shares Leuprolide (leuprorelin) and GnRH agonists, Prostate cancer.
- TreatmentHistrelin
Shares GnRH receptor (GNRHR), Leuprolide (leuprorelin) and GnRH agonists, Prostate cancer.
- TreatmentBuserelin
Shares GnRH receptor (GNRHR), Leuprolide (leuprorelin) and GnRH agonists, Prostate cancer.
- TrialFlutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer
Shares Leuprolide (leuprorelin) and GnRH agonists, Prostate cancer.
- TrialAssessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT
Shares Leuprolide (leuprorelin) and GnRH agonists, Prostate cancer.
cancers
fronts
targets
drugs
ApprovedGnRH agonist depot
Leuprolide (leuprorelin) and GnRH agonists · Lupron / Eligard / Camcevi